These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6894970)

  • 1. The Graves' enigma: breaking an immunological code.
    Jakobiec FA; Henkind P
    Ophthalmology; 1981 Jun; 88(6):26A-27A. PubMed ID: 6894970
    [No Abstract]   [Full Text] [Related]  

  • 2. Current insights into animal models of Graves' disease and orbitopathy.
    Wiesweg B; Johnson KT; Eckstein AK; Berchner-Pfannschmidt U
    Horm Metab Res; 2013 Aug; 45(8):549-55. PubMed ID: 23613015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graves' hyperthyroidism and endocrine ophthalmopathy--one or two closely related diseases?
    Volpé R
    Dev Ophthalmol; 1993; 25():101-11. PubMed ID: 8359344
    [No Abstract]   [Full Text] [Related]  

  • 4. Graves' disease: clinical correlation with autoantibody activity.
    Valente WA
    Md Med J; 1988 Nov; 37(11):866-9. PubMed ID: 3054388
    [No Abstract]   [Full Text] [Related]  

  • 5. Circulating monocyte migration inhibitory factor in serum of Graves' ophthalmopathy patients: a parameter for disease activity?
    van der Gaag R; Broersma L; Mourits MP; Koornneef L; Wiersinga WM; Prummel MP; Berghout A
    Clin Exp Immunol; 1989 Feb; 75(2):275-9. PubMed ID: 2649288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of Mouse Models of Graves' Disease and Orbitopathy-Novel Treatment by Induction of Tolerance.
    Ungerer M; Faßbender J; Li Z; Münch G; Holthoff HP
    Clin Rev Allergy Immunol; 2017 Apr; 52(2):182-193. PubMed ID: 27368808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological activity of antibodies circulating in endocrine ophthalmopathy.
    Nauman JA
    Dev Ophthalmol; 1993; 25():29-37. PubMed ID: 8359351
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy.
    Weetman AP; Cohen S; Gatter KC; Fells P; Shine B
    Clin Exp Immunol; 1989 Feb; 75(2):222-7. PubMed ID: 2784734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated anti-alpha-galactosyl antibody titres. A marker of progression in endocrine ophthalmopathy and in auto-immune thyroid disorders?
    Winand R
    Dev Ophthalmol; 1993; 25():38-45. PubMed ID: 8359352
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of HLA antigen BW35 with severe Graves' ophthalmopathy.
    Sergott RC; Felberg NT; Savino PJ; Blizzard JJ; Schatz NJ; Sanford CA
    Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):124-7. PubMed ID: 6600737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy.
    Salvi M; Bingoye F; Chung F; Wall JR
    J Clin Endocrinol Metab; 1988 May; 66(5):939-45. PubMed ID: 3360902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients.
    van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
    Thyroid; 2010 May; 20(5):535-44. PubMed ID: 20384487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Orbit pathology and Graves' ophthalmopathy].
    Stankiewicz A
    Klin Oczna; 1997; 99(1):59-63. PubMed ID: 9379657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy: identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay.
    Ahmann A; Baker JR; Weetman AP; Wartofsky L; Nutman TB; Burman KD
    J Clin Endocrinol Metab; 1987 Mar; 64(3):454-60. PubMed ID: 2434519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of antibodies in the sera of patients with Graves' disease recognizing a 23 kilodalton fibroblast protein.
    Bahn RS; Gorman CA; Johnson CM; Smith TJ
    J Clin Endocrinol Metab; 1989 Sep; 69(3):622-8. PubMed ID: 2760173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical staining of normal and Graves' extraocular muscle.
    Tallstedt L; Norberg R
    Invest Ophthalmol Vis Sci; 1988 Feb; 29(2):175-84. PubMed ID: 2448263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of graves' orbitopathy: early diagnosis of thyroid-associated orbitopathy in Graves' disease.
    Mourits MP
    Orbit; 2008; 27(6):399-400. PubMed ID: 19085291
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunopathology of Graves'-Basedow disease].
    Baj Z; Ferenc T; Lewiński A
    Postepy Hig Med Dosw; 1997; 51(5):531-46. PubMed ID: 9489453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative immunological differences between newly diagnosed Graves' disease patients and relapsed patients.
    Di Mario U; Cavatorta FP; Perfetti R; Pugliese G; Pozzilli P; Sutherland J; Vitillo M; Andreani D
    J Endocrinol Invest; 1988 Feb; 11(2):85-9. PubMed ID: 3258878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of genetics in Graves' disease and thyroid orbitopathy.
    Kim N; Hatton MP
    Semin Ophthalmol; 2008; 23(1):67-72. PubMed ID: 18214794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.